No Data
No Data
Cantor Fitzgerald Initiates Vaxcyte(PCVX.US) With Buy Rating
Cantor Fitzgerald Initiates Coverage On Vaxcyte With Overweight Rating
TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $135
Shares of Vaccine Stocks Are Trading Lower After CDC Advisers Begins a Review of Vaccine Guidelines and Discussed a More Narrow Use of COVID-19 Booster Shots.
Express News | Shares of Vaccine Stocks Are Trading Lower After CDC Advisers Begins a Review of Vaccine Guidelines and Discussed a More Narrow Use of COVID-19 Booster Shots
Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans